IPA to Present at The Microcap Conference 2025
IPA to Present at The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, in Atlantic City, NJ.
維多利亞，BC / ACCESSWIRE / 2024年12月19日 / IPA（免疫精確抗體有限公司）（"公司"或"IPA"）（納斯達克：IPA），一家以人工智能驅動的生物治療研究及科技公司，今天高興地宣佈將參加2025年微型資本會議，這是一個專注於增長的公司和投資者的頂級活動。會議將在2025年1月28日至30日在新澤西州的亞特蘭大市舉行。
IPA's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
IPA的管理團隊將進行公司介紹，並與機構和個人投資者進行一對一會議，以討論公司的最新進展、增長策略和投資機會。
About The Microcap Conference 2025
關於2025年微型資本大會
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from microcap companies. The event offers a platform for companies to showcase their value propositions through presentations, one-on-one meetings, and networking opportunities.
微型資本大會是美國最大的獨立微型資本活動，匯聚了來自微型資本公司的頂尖投資者和高管。該活動爲公司提供了一個通過演示、一對一會議和網絡交流機會展示其價值主張的平台。
The 2025 event will feature:
2025年活動將有：
Keynote Speakers: Renowned industry figures, including Jon Ledecky, Co-Owner of the New York Islanders, who will engage in a fireside chat with CNBC's Bob Pisani; plus Tom Gardner, CEO of Motley Fool, who will share insights on investing, market trends, and entrepreneurial success.
Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover critical topics for the US equity markets, from capital formation to regulatory updates and market trends.
Entertainment Headliner: A special performance by Tom Papa, celebrated comedian and host of Netflix specials, ensuring a memorable evening for attendees.
主旨演講人：知名行業人物，包括紐約島人隊的共同所有者Jon Ledecky，他將與CNBC的Bob Pisani進行爐邊聊天；另外，財經智囊Tom Gardner，莫特利傻瓜公司的首席執行官，將分享關於投資、市場趨勢和企業成功的見解。
專家小組和演講：財經評論員Ron Insana（CNBC）和Charlie Gasparino（FOX商業）將討論關於美國股市的重要話題，從資本形成到監管更新和市場趨勢。
娛樂頭條：享有盛譽的喜劇演員Tom Papa將帶來特別表演，並主持奈飛特別節目，爲與會者帶來難忘的夜晚。
Hosted by DealFlow Events, The Microcap Conference is renowned for its blend of high-quality content, engaging networking, and exceptional entertainment. For more information, visit .
由DealFlow Events主辦的微型資本會議因高質量的內容、引人入勝的網絡交流和卓越的娛樂而聞名。如需更多信息，請訪問。
About ImmunoPrecise Antibodies Ltd.
關於ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and is known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA Family").
ImmunoPrecise Antibodies Ltd.是一家生物技術公司，利用多組學建模和複雜的人工智能，通過一系列專有和專利技術。該公司擁有一整套集成的端到端能力，以支持治療性抗體的開發，並以解決複雜行業挑戰而聞名。IPA在北美和歐洲擁有數個子公司，包括Talem Therapeutics LLC、BioStrand BV、ImmunoPrecise Antibodies (Canada) Ltd.和ImmunoPrecise Antibodies (Europe) b.V.（統稱爲「IPA家族」）。
Investor Relations Contact
投資者關係聯繫人
investors@ipatherapeutics.com
investors@ipatherapeutics.com
SOURCE: ImmunoPrecise Antibodies Ltd.
來源：ImmunoPrecise Antibodies Ltd.
譯文內容由第三人軟體翻譯。
